Sector valuations Hangzhou Tigermed Consulting Co., Ltd
Equities
300347
CNE100001KV8
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.11 CNY | -1.25% |
|
-3.94% | -2.80% |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 40x | 2.17x | 0.21x | 6.4x | 25.01x | 32.26x | 0.82% | 6.51B | ||
| 33.07x | 3.45x | 0.52x | 4.92x | 16.5x | 24.16x | 1.02% | 42.78B | ||
| 51.27x | 6.61x | 0.43x | 4.42x | 29.75x | 37.55x | -.--% | 31.5B | ||
| 54.26x | 2.59x | 0.59x | 11.14x | 30.96x | 39.97x | 0.35% | 29.99B | ||
| 19.97x | 3.58x | 3.84x | 2.36x | 10.18x | 15.43x | -.--% | 27.65B | ||
| -12.38x | 16.77x | -0.43x | 320.84x | -10.44x | -10.35x | -.--% | 18.8B | ||
| 43.12x | 159.3x | -0.19x | 8.22x | 25.82x | 33.47x | -.--% | 13.87B | ||
| 26.34x | 13.13x | 2.21x | 4.19x | 19.06x | 19.99x | -.--% | 12.78B | ||
| 20.1x | 2.28x | 0.54x | 1.87x | 8.16x | 12.57x | 1.23% | 12.39B | ||
| -17.61x | -48.43x | -0.25x | 13.71x | -19.11x | -17.59x | -.--% | 11.76B | ||
| -32.82x | 18.81x | -3.24x | 1312.71x | -35.66x | -33.1x | - | 9.01B | ||
| -31.26x | 21.06x | -2.33x | 6x | 147.84x | -290.99x | -.--% | 8.94B | ||
| 20.7x | 2.31x | 0.05x | 4.23x | 11.5x | 14.26x | 0.5% | 8.37B | ||
| -19.5x | 7.28x | -1.65x | 1102.56x | -16.23x | -16.04x | -.--% | 8.19B | ||
| 40.46x | 3.66x | 0.23x | 6.44x | 18.03x | 19.85x | 0.63% | 7.96B | ||
| 19.96x | - | -0.05x | - | - | - | -.--% | 7.65B | ||
| 15.21x | 0.8x | -0.47x | 1.31x | 6.66x | 7.42x | -.--% | 7.51B | ||
| 28.35x | 3.3x | -9.21x | 3.59x | 14.72x | 23.15x | 0.72% | 6.84B | ||
| Average | 16.62x | 12.86x | -0.51x | 165.58x | 16.63x | -5.18x | 0.31% | 15.14B | |
| Weighted average by Cap. | 23.61x | 12.05x | 0.20x | 106.50x | 17.20x | 7.50x | 0.34% |
- Stock Market
- Equities
- 300347 Stock
- Sector Hangzhou Tigermed Consulting Co., Ltd
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















